Literature DB >> 34888846

Metabolic Interactions Between Tumor and Stromal Cells in the Tumor Microenvironment.

Deepshikha Mishra1, Debabrata Banerjee2.   

Abstract

In this chapter, we provide information about metabolic reprogramming in cancer cells, molecular interactions between tumor and stromal cells in the tumor microenvironment, focusing primarily on CAFs and tumor cell interaction. We have covered the role of cytokines, chemokines, and lactate in driving tumor-stroma interactions in the microenvironment. Here, we have discussed the pro-tumorigenic molecular interactions in between tumor cells and CAFs mediated via altered signaling pathways, cytokines, chemokines, and lactate in the tumor vicinity. A better understanding of the complex cancer cell-CAF interactions will help in designing successful therapeutic strategies targeting the stromal-rich tumors in the clinic.
© 2021. Springer Nature Switzerland AG.

Entities:  

Keywords:  CAFs; Cytokines; Lactate; Metabolic cooperation; Pyruvate; Tumor microenvironment

Mesh:

Year:  2021        PMID: 34888846     DOI: 10.1007/978-3-030-83282-7_5

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  79 in total

Review 1.  Cancer and the chemokine network.

Authors:  Fran Balkwill
Journal:  Nat Rev Cancer       Date:  2004-07       Impact factor: 60.716

2.  The tumor microenvironment at a glance.

Authors:  Frances R Balkwill; Melania Capasso; Thorsten Hagemann
Journal:  J Cell Sci       Date:  2012-12-01       Impact factor: 5.285

Review 3.  Jekyll and Hyde: the role of the microenvironment on the progression of cancer.

Authors:  Michael Allen; J Louise Jones
Journal:  J Pathol       Date:  2010-10-29       Impact factor: 7.996

Review 4.  The significance of cancer cell expression of the chemokine receptor CXCR4.

Authors:  Fran Balkwill
Journal:  Semin Cancer Biol       Date:  2004-06       Impact factor: 15.707

5.  Macrophage-associated mesenchymal stem cells assume an activated, migratory, pro-inflammatory phenotype with increased IL-6 and CXCL10 secretion.

Authors:  Kevin Anton; Debabrata Banerjee; John Glod
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

6.  Cancer-associated fibroblasts secrete Wnt2 to promote cancer progression in colorectal cancer.

Authors:  Takashi Aizawa; Hideaki Karasawa; Ryo Funayama; Matsuyuki Shirota; Takashi Suzuki; Shimpei Maeda; Hideyuki Suzuki; Akihiro Yamamura; Takeshi Naitoh; Keiko Nakayama; Michiaki Unno
Journal:  Cancer Med       Date:  2019-08-29       Impact factor: 4.452

Review 7.  Lactate Beyond a Waste Metabolite: Metabolic Affairs and Signaling in Malignancy.

Authors:  Fátima Baltazar; Julieta Afonso; Marta Costa; Sara Granja
Journal:  Front Oncol       Date:  2020-03-18       Impact factor: 6.244

8.  Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts.

Authors:  Jean Albrengues; Thomas Bertero; Eloise Grasset; Stephanie Bonan; Majdi Maiel; Isabelle Bourget; Claude Philippe; Cecilia Herraiz Serrano; Samia Benamar; Olivier Croce; Victoria Sanz-Moreno; Guerrino Meneguzzi; Chloe C Feral; Gael Cristofari; Cedric Gaggioli
Journal:  Nat Commun       Date:  2015-12-15       Impact factor: 14.919

Review 9.  Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts.

Authors:  Angelica Avagliano; Giuseppina Granato; Maria Rosaria Ruocco; Veronica Romano; Immacolata Belviso; Antonia Carfora; Stefania Montagnani; Alessandro Arcucci
Journal:  Biomed Res Int       Date:  2018-06-05       Impact factor: 3.411

10.  Integrative metabolic and transcriptomic profiling of prostate cancer tissue containing reactive stroma.

Authors:  Maria K Andersen; Kjersti Rise; Guro F Giskeødegård; Elin Richardsen; Helena Bertilsson; Øystein Størkersen; Tone F Bathen; Morten Rye; May-Britt Tessem
Journal:  Sci Rep       Date:  2018-09-24       Impact factor: 4.379

View more
  1 in total

Review 1.  The systemic-level repercussions of cancer-associated inflammation mediators produced in the tumor microenvironment.

Authors:  Dolores Aguilar-Cazares; Rodolfo Chavez-Dominguez; Mario Marroquin-Muciño; Mario Perez-Medina; Jesus J Benito-Lopez; Angel Camarena; Uriel Rumbo-Nava; Jose S Lopez-Gonzalez
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-22       Impact factor: 6.055

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.